Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains
Abstract
:1. Introduction
2. Experimental Section
2.1. Sample and Records
2.2. Glaucoma Medications
2.3. Adherence Estimation
3. Results
4. Discussion
5. Conclusions
Acknowledgments
Author Contributions
Conflicts of Interest
References
- Osterberg, L.; Blaschke, T. Adherence to medication. N. Engl. J. Med. 2005, 353, 487–497. [Google Scholar] [CrossRef] [PubMed]
- Marcum, Z.A.; Sevick, M.A.; Handler, S.M. Medication nonadherence: A diagnosable and treatable medical condition. JAMA 2013, 309, 2105–2106. [Google Scholar] [CrossRef] [PubMed]
- Quigley, H.A.; Broman, A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Ophthalmol. 2006, 90, 262–267. [Google Scholar] [CrossRef] [PubMed]
- Bansal, R.; Tsai, J. Compliance/Adherence to Glaucoma Medications—A Challenge. J. Curr. Glaucoma Pract. 2007, 1, 22–25. [Google Scholar] [CrossRef]
- Alany, R.G. Adherence, persistence and cost-consequence comparison of bimatoprost topical ocular formulations. Curr. Med. Res. Opin. 2013, 29, 1187–1189. [Google Scholar] [CrossRef] [PubMed]
- Okeke, C.O.; Quigley, H.A.; Jampel, H.D.; Ying, G.; Plyler, R.J.; Jiang, Y.; Friedman, D.S. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology 2009, 116, 191–199. [Google Scholar] [CrossRef] [PubMed]
- Schwartz, G.F.; Quigley, H.A. Adherence and persistence with glaucoma therapy. Surv. Ophthalmol. 2008, 53, S57–S68. [Google Scholar] [CrossRef] [PubMed]
- Cate, H.; Bhattacharya, D.; Clark, A.; Holland, R.; Broadway, D.C. Patterns of adherence behaviour for patients with glaucoma. Eye (Lond.) 2013, 27, 545–553. [Google Scholar] [CrossRef] [PubMed]
- Cate, H.; Bhattacharya, D.; Clark, A.; Fordham, R.; Holland, R. Improving adherence to glaucoma medication: A randomised controlled trial of a patient-centred intervention (The Norwich Adherence Glaucoma Study). BMC Ophthalmol. 2014, 14, 32. [Google Scholar] [CrossRef] [PubMed]
- Rossi, G.C.M.; Pasinetti, G.M.; Scudeller, L.; Radaelli, R.; Bianchi, P.E. Do adherence rates and glaucomatous visual field progression correlate? Eur. J. Ophthalmol. 2011, 21, 410–414. [Google Scholar] [CrossRef] [PubMed]
- Sleath, B.; Blalock, S.; Covert, D.; Stone, J.L.; Skinner, A.C.; Muir, K.; Robin, A.L. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology 2011, 118, 2398–2402. [Google Scholar] [CrossRef] [PubMed]
- Lee, M.D.; Fechtner, F.R.; Fiscella, R.G.; Singh, K.; Stewart, W.C. Emerging perspectives on glaucoma: Highlights of a roundtable discussion. Am. J. Ophthalmol. 2000, 130, S1–S11. [Google Scholar] [CrossRef]
- Tsai, J.C.; McClure, C.A.; Ramos, S.E.; Schlundt, D.G.; Pichert, J.W. Compliance barriers in glaucoma: A systematic classification. J. Glaucoma 2003, 12, 393–398. [Google Scholar] [CrossRef] [PubMed]
- Loon, S.C.; Jin, J.; Jin Goh, M. The relationship between quality of life and adherence to medication in glaucoma patients in Singapore. J. Glaucoma 2015, 24, e36–e42. [Google Scholar] [CrossRef] [PubMed]
- Robin, A.; Grover, D.S. Compliance and adherence in glaucoma management. Indian J. Ophthalmol. 2011, 59, S93–S96. [Google Scholar] [CrossRef] [PubMed]
- Boland, M.V.; Chang, D.S.; Frazier, T.; Plyler, R.; Friedman, D.S. Electronic monitoring to assess adherence with once-daily glaucoma medications and risk factors for nonadherence: The automated dosing reminder study. JAMA Ophthalmol. 2014, 132, 838–844. [Google Scholar] [CrossRef] [PubMed]
- Sattler, E.L.P.; Lee, J.S.; Perri, M. Medication (Re)fill Adherence Measures Derived from Pharmacy Claims Data in Older Americans: A Review of the Literature. Drugs Aging 2013, 30, 383–399. [Google Scholar] [CrossRef] [PubMed]
- Morisky, D.E.; Ang, A.; Krousel-Wood, M.; Ward, H.J. Predictive Validity of a Medication Adherence Measure in an Outpatient Setting. J. Clin. Hypertens. 2008, 10, 348–354. [Google Scholar] [CrossRef]
- Friedman, D.S.; Quigley, H.A.; Gelb, L.; Tan, J.; Margolis, J.; Shah, S.N.; Kim, E.E.; Zimmerman, T.; Hahn, S.R. Using pharmacy claims data to study adherence to glaucoma medications: Methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Investig. Ophthalmol. Vis. Sci. 2007, 48, 5052–5057. [Google Scholar] [CrossRef] [PubMed]
- Bernsten, C.; Björkman, I.; Caramona, M.; Crealey, G.; Frøkjaer, B.; Grundberger, E.; Gustafsson, T.; Henman, M.; Herborg, H.; Hughes, C.; et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: A multicentre study in seven European countries. Drugs Aging 2001, 18, 63–77. [Google Scholar] [CrossRef] [PubMed]
- Grant, R.W.; Devita, N.G.; Singer, D.E.; Meigs, J.B. Improving adherence and reducing medication discrepancies in patients with diabetes. Ann. Pharmacother. 2003, 37, 962–969. [Google Scholar] [CrossRef] [PubMed]
- Lee, J.K.; Grace, K.A.; Taylor, A.J. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized controlled trial. JAMA 2006, 296, 2563–2571. [Google Scholar] [CrossRef] [PubMed]
- Sturgess, I.K.; McElnay, J.C.; Hughes, C.M.; Crealey, G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm. World Sci. 2003, 25, 218–226. [Google Scholar] [CrossRef] [PubMed]
- Williams, G.C.; Niemiec, C.P.; Patrick, H.; Ryan, R.M.; Deci, E.L. The importance of supporting autonomy and perceived competence in facilitating long-term tobacco abstinence. Ann. Behav. Med. 2009, 37, 315–324. [Google Scholar] [CrossRef] [PubMed]
- Agents for Glaucoma. Facts & Comparisons [Database Online]; Wolters Kluwer Health Inc.: St. Louis, MO, USA, 2015; (accessed on 1 November 2015). [Google Scholar]
- Martin, B.C.; Wiley-Exley, E.K.; Richards, S.; Domino, M.E.; Carey, T.S.; Sleath, B.L. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann. Pharmacother. 2009, 43, 36–44. [Google Scholar] [CrossRef] [PubMed]
- Sikka, R.; Xia, F.; Aubert, R.E. Estimating medication persistency using administrative claims data. Am. J. Manag. Care 2005, 11, 449–457. [Google Scholar] [PubMed]
- Nau, D.P. Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence. Available online: http://www.pqaalliance.org/images/uploads/files/PQA%20PDC%20vs%20%20MPR.pdf (accessed on 6 July 2016).
- Feehan, M.; Ranker, L.; Durante, R.; Cooper, D.K.; Jones, G.J.; Young, D.C.; Munger, M.A. Adherence to controller asthma medications: 6-month prevalence across a US community pharmacy chain. J. Clin. Pharm. Ther. 2015. [Google Scholar] [CrossRef] [PubMed]
- Janz, N.K. The health belief model: A decade later. Health Educ. Q. 1984, 11, 1–47. [Google Scholar] [CrossRef] [PubMed]
- Haga, S.B.; LaPointe, N.M.A. The potential impact of pharmacogenetic testing on medication adherence. Pharmacogenomics J. 2013, 13, 481–483. [Google Scholar] [CrossRef] [PubMed]
- Newman-Casey, P.A.; Dayno, M.; Robin, A.L. Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015. Exp. Rev. Ophthalmol. 2016, 11, 5–20. [Google Scholar] [CrossRef] [PubMed]
Sex | Age (Years) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Total | Female | Male | Statistic | P-Value | 18–44 | 45–64 | 65 and Over | Statistic | P-Value | |
(n = 3615) | (n = 2074) | (n = 1541) | (n = 275) | (n = 843) | (n = 2497) | |||||
Proportion of Days Covered (PDC) | ||||||||||
Mean percent PDC (SD *) | 57 (35) | 57 (35) | 56 (35) | t = 0.85 | 0.394 | 29 (29) | 48 (33) | 62 (34) | F = 164.8 | <0.001 |
Number with satisfactory PDC 1 (%) | 1070 (30) | 622 (30) | 448 (29) | χ2 = 0.36 | 0.550 | 26 (9) | 164(19) | 880 (35) | χ2 = 133.3 | <0.001 |
Medicine Possession Ratio (MPR) | ||||||||||
Mean percent MPR (SD *) | 71 (59) | 72 (59) | 71 (60) | t = 0.19 | 0.849 | 34 (42) | 58 (53) | 80 (61) | F = 108.1 | <0.001 |
Number with satisfactory MPR1 (%) | 1342 (37) | 783 (38) | 559 (36) | χ2 = 0.83 | 0.363 | 36 (13) | 229 (27) | 1077 (43) | χ2 = 142.5 | <0.001 |
© 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Feehan, M.; Munger, M.A.; Cooper, D.K.; Hess, K.T.; Durante, R.; Jones, G.J.; Montuoro, J.; Morrison, M.A.; Clegg, D.; Crandall, A.S.; et al. Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains. J. Clin. Med. 2016, 5, 79. https://doi.org/10.3390/jcm5090079
Feehan M, Munger MA, Cooper DK, Hess KT, Durante R, Jones GJ, Montuoro J, Morrison MA, Clegg D, Crandall AS, et al. Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains. Journal of Clinical Medicine. 2016; 5(9):79. https://doi.org/10.3390/jcm5090079
Chicago/Turabian StyleFeehan, Michael, Mark A. Munger, Daniel K. Cooper, Kyle T. Hess, Richard Durante, Gregory J. Jones, Jaime Montuoro, Margaux A. Morrison, Daniel Clegg, Alan S. Crandall, and et al. 2016. "Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains" Journal of Clinical Medicine 5, no. 9: 79. https://doi.org/10.3390/jcm5090079